Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Biologics

EULAR 2014: Collaboration Among Rheumatology Groups Expected to Build

Thomas R. Collins  |  September 1, 2014

ACR, European League Against Rheumatism, other groups, to work together creating disease criteria and response sets, patient management guidelines

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesEULAR/OtherMeeting Reports Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicscollaborationCollinsdrugEULARGlucocorticoidsInternationalpatient carePolymyalgia RheumaticarheumatologySafetyTofacitinib

Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians

Kathy Holliman  |  September 1, 2014

Infectious Diseases Society of America recommends both physician groups educate patients, household members on importance of vaccines

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug Updates Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugGuidelinesHollimanimmunocompromisedMethotrexatepatient carerheumatologistSafetyvaccination

The ACR’s Advocates for Arthritis Volunteers Meet with Congress

Staff  |  September 1, 2014

Access to rheumatology patient care, treatment, research funding on the agenda

Filed under:From the CollegeLegislation & AdvocacyProfessional TopicsResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)ArthritisCongressdrugLegislationMedicarepatient careResearchrheumatology

Update on Legislation, Advocacy Efforts to Advance Rheumatology

Joseph Flood, MD  |  September 1, 2014

Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress

Filed under:Billing/CodingBiologics/DMARDsDrug UpdatesLegislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsQuality Assurance/ImprovementResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BillingBiologicsBiosimilarsCodingdrugICD-10LegislationMedicarePractice ManagementResearchrheumatologistSGRTechnology

EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis

Thomas R. Collins  |  August 1, 2014

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:Ankylosing Spondylitisanti-inflammatoryBiologicsCollinsdrugEULARGlucocorticoidsinfliximabInternationalMethotrexateResearchRheumatoid arthritisrheumatologySafety

Is Shared Decision Making Possible in Rheumatology?

James T. Rosenbaum, MD  |  August 1, 2014

A rheumatologist voices skepticism that physicians, patients can arrive at mutually shared healthcare decisions

Filed under:Biologics/DMARDsConditionsDrug UpdatesOther Rheumatic ConditionsPractice SupportQuality Assurance/ImprovementRheumatoid ArthritisWorkforce Tagged with:BiologicsdrugMedicareMethotrexatepatient carephysicianPractice ManagementprednisoneRheumatoid arthritisrheumatologistSarcoidosisSteroids

Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support

Gretchen Henkel  |  July 1, 2014

Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugEULARGlucocorticoidsLupusprednisoneRheumatoid arthritisrheumatologistrituximabSLESystemic lupus erythematosus

Hospitalists Gain Insight on Signs, Symptoms of Infection Among Inpatients on Biologic Drugs

Richard Quinn  |  June 6, 2014

Rheumatologist at Society of Hospital Medicine conference provides treatment recommendations for hospital patients with rheumatic disease

Filed under:Practice Support Tagged with:biologic drugsInfectioninpatientrheumatology

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  June 1, 2014

Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisResearch Rheum Tagged with:anti-inflammatoryBiologicsBiosimilarscelecoxib (Elyxyb)corticosteroid psychosisMethotrexatePsoriatic ArthritisradiographraloxifeneResearchrituximabSafety

Lessons Learned from a Patient with Rheumatoid Arthritis

Sarah Troxell, RN, BSN  |  June 1, 2014

Sarah Troxell, RN, BSN, imparts what she’s learned about RA and medication management, assembling a team of health professionals and battling other health issues

Filed under:ConditionsOther Rheumatic ConditionsProfilesRheumatoid Arthritis Tagged with:Antiphospholipid Antibody Syndrome (APS)Association of Rheumatology Professionals (ARP)BiologicsHughes SyndromeMethotrexateprednisoneProfileRARheumatoid arthritisrheumatologistrituximabTroxell

  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 76
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences